Abbott Laboratories buy BTIG Research
Start price
20.11.25
/
50%
€107.90
Target price
20.11.26
€125.82
Performance (%)
-16.90%
Price
17:53
€89.67
Summary
This prediction is currently active. The price of Abbott Laboratories has decreased since the start of the prediction. Compared to the start price this results in a performance of -16.90%. This prediction currently runs until 20.11.26. The prediction end date can be changed by BTIG_Research at any time. BTIG_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Abbott Laboratories | -12.217% | -12.217% |
| iShares Core DAX® | -0.121% | 2.507% |
| iShares Nasdaq 100 | 0.081% | -0.241% |
| iShares Nikkei 225® | -1.748% | 4.105% |
| iShares S&P 500 | -0.961% | -0.143% |
Comments by BTIG_Research for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE:ABT) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $145.00 price target on the stock.
Ratings data for ABT provided by MarketBeat
Stopped prediction by BTIG_Research for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€93.02
23.01.26
23.01.26
€119.18
23.01.27
23.01.27
-3.41%
17:53
17:53
Abbott Laboratories
Start price
Target price
Perf. (%)
€110.96
16.10.25
16.10.25
€124.21
16.10.26
16.10.26
-19.02%
17:53
17:53
Abbott Laboratories
Start price
Target price
Perf. (%)
€104.68
18.07.25
18.07.25
€124.73
18.07.26
18.07.26
-14.17%
17:53
17:53